Boardroom Alpha
8-K primary document
MNTK · Current Report (Form 8-K) · Filed August 6, 2026

Montauk Renewables Inc8-K exhibit

d85806dex991.htm
EX-99.1

Exhibit 99.1

MONTAUK RENEWABLES, INC.

Incorporated in the United States of America

Company number: 85-3189583

NASDAQ share code: MNTK

JSE share code: MKR

ISIN: US61218C1036

(“Montauk Renewables” or the “Company”)

UNAUDITED CONSOLIDATED RESULTS

For the six months ended 30 June 2026

Dollar amounts presented herein are in United States Dollars

SALIENT FEATURES

 

           

2026

Six months
Ended 30 June

     2025
Six months
Ended 30 June
     Percentage
change
 

Revenue

   ($ ‘000      100 447        87 730        14

EBITDA

   ($ ‘000      21 066        11 360        85

Headline earnings/(loss)

   ($ ‘000      1 084        (4 008      127

Earnings/(loss) per share

   ($        0.00        (0.04      100

Headline earnings/(loss) per common share

   ($        0.01        (0.03      133

Net asset value per common share

   ($        1.85        1.78        4

DECLARATION OF CASH DIVIDEND

The directors have resolved not to declare a final dividend to focus financial resources on the continued development of the Company’s operations portfolio.

USE OF NON-GAAP MEASURES

This report was prepared for the purpose of complying with the reporting requirements of the Johannesburg Stock Exchange and includes certain non-GAAP measures, such as headline earnings and headline earnings per common share, and related reconciliations.

Reconciliation of headline earnings

 

    

2026

Six months

Ended 30 June

    

2025

Six months

Ended 30 June

 
     Gross $‘000      Net $‘000      Gross $‘000      Net $‘000  

Net income/(loss) attributable to common shareholders

        231           (5 951

Adjustments

           

(Gain) /loss on disposal of plant and Equipment

     (13      (10      36        28  

Impairment of plant and equipment

     1 093        863        2 424        1 915  

Headline earnings/(loss)

        1 084           (4 008

Basic and headline earnings/(loss) per common share (US Dollars)

           

Earnings/(loss)

        0.00           (0.04

Headline earnings/(loss)

        0.01           (0.03

Weighted-average common shares outstanding (‘000)(1)

        143 245           142 875  

Diluted earnings/(loss) per common share (US Dollars)

           

Earnings/(loss)

        0.00           (0.04

Headline earnings/(loss)

        0.01           (0.03

Weighted-average common shares outstanding for diluted (‘000)

        143 917           142 875  

 

(1)

The common share outstanding as of June 30, 2026 is as reported in the quarterly report on Form 10-Q for the fiscal quarter ended June 30, 2026, filed with the Securities and Exchange Commission on August 5, 2026.

FORM 10-Q QUARTERLY REPORT and FORM 8-K CURRENT REPORT

Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934, Montauk Renewables stockholders are advised that a Form 10-Q and Form 8-K has been filed with the SEC. The Form 10-Q disclose the quarterly results and related disclosures for the quarterly period ended 30 June 2026. The Form 8-K discloses the press release announcing the quarterly results for the second quarter ended 30 June 2026.

A copy of the Form 10-Q can be found at:

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001826600/000119312526335335/mntk-20260630.htm

A copy of the Form 8-K can be found at:

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001826600/000119312526335293/mntk-20260805.htm

DIRECTORS’ STATEMENT

This short-form announcement is the responsibility of the Company’s Board of Directors.


The financial information is only a summary and does not contain full details of the financial results. Any investment decisions by investors and/or shareholders should be based on information contained in the full announcement, accessible from August 6, 2026, via the JSE link https://senspdf.jse.co.za/documents/2026/jse/isse/MKRE/HY26.pdf. The full announcement is also available on the Company’s website https://ir.montaukrenewables.com/ to comply with paragraph 6.35(c)(i) of the JSE Listings Requirements.

August 6, 2026

Directors: JA Copelyn (Chairman)*###, SF McClain (Chief Executive Officer)#,

MH Ahmed*###, TG Govender*###, J Cunningham*#, Y Shaik* ###

 

*

Non-executive; #United States of America; ### Republic of South Africa

Company secretary: J Ciroli

Registered office: 5313 Campbells Run Road, Suite 200, Pittsburgh, PA 15205

Website: https://ir.montaukrenewables.com/

Montauk Renewables is primary listed on the Nasdaq and secondary listed on the JSE.

Sponsor:

Investec Bank Limited

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer